Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.
- DOI
- 10.1016/j.ejca.2018.07.136
- Published
- 2018 Nov
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2018.07.136,
title = {Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.},
author = {Cabarrou B and Sfumato P and Mourey L and Leconte E and Balardy L and Martinez A and Delord JP and Boher JM and Brain E and Filleron T},
year = {2018},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2018.07.136},
url = {https://doi.org/10.1016/j.ejca.2018.07.136}
}RIS
TY - JOUR TI - Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology. AU - Cabarrou B AU - Sfumato P AU - Mourey L AU - Leconte E AU - Balardy L AU - Martinez A AU - Delord JP AU - Boher JM AU - Brain E AU - Filleron T PY - 2018 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2018.07.136 UR - https://doi.org/10.1016/j.ejca.2018.07.136 ER -
APA
B, C., P, S., L, M., E, L., L, B., A, M., JP, D., JM, B., E, B., & T, F. (2018). Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2018.07.136
Source records
- pubmed · retrieved 2026-09-25T00:25:51.145Z